Latest Content by PharmaCompass
01 1(S)-8-ETHYL-8-HYDROXY-2,3,5,8-TETRAHYDRO-6-OXA-3A-AZA-CYCLOPENTA[B]NAPHTHALENE-1,4,7-TRIONE (400012)
02 11-ACETAMIDO 3,5-DIMETHYL ADAMANTANE
03 17-ETHYL-10-HYDROXYCAMPTOTHECIN
04 1APIXABAN
05 1ARIPIPRAZOLE USP
06 1ATOMOXETINE HYDROCHLORIDE USP
07 1BACLOFEN USP
08 1CLOZAPINE USP
09 1D-THREO RITALINIC ACID HYDROCHLORIDE
10 1DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE
11 1DAPSONE USP
12 1DIFLUNISAL USP
13 1DIPYRIDAMOLE USP
14 1DOXAZOSIN MESYLATE USP
15 1EMPAGLIFLOZIN
16 1ENTACAPONE USP
17 1ESLICARBAZEPINE ACETATE
18 1FERRIC CITRATE
19 1FLURBIPROFEN USP
20 1FLUVOXAMINE MALEATE USP
21 1HYDRALAZINE HYDROCHLORIDE USP
22 1ITRACONAZOLE USP
23 1LAMOTRIGINE USP
24 1LEVOCETIRIZINE DIHYDROCHLORIDE USP
25 1LURASIDONE HYDROCHLORIDE
26 1MARAVIROC
27 1MECLIZINE HYDROCHLORIDE USP
28 1MEMANTINE HYDROCHLORIDE USP
29 1MENTHADIENOL
30 1METAXALONE USP
31 1MEXILETINE HYDROCHLORIDE USP
32 1MIDAZOLAM USP
33 1MIRABEGRON
34 1OLIVETOL
35 1PIRFENIDONE
36 1PIRIBEDIL
37 1POSACONAZOLE
38 1QUETIAPINE FUMARATE USP
39 1RITALINIC ACID
40 1RIVAROXABAN
41 1TAMSULOSIN HYDROCHLORIDE USP
42 1THREO PHENYL-2- PIPERIDYL ACETAMIDE
43 1TICAGRELOR
44 1TOLCAPONE USP
45 1VANILLYLAMINE HYDROCHLORIDE
46 1VENLAFAXINE HYDROCHLORIDE USP
47 1VERAPAMIL HYDROCHLORIDE USP
48 2ZONISAMIDE USP
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39042
Submission : 2023-10-20
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 33684
Submission : 2019-03-29
Status : Active
Type : II
KEY PRODUCTS
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
